FDA requires black box warnings for combining benzodiazepines and opioids
The Food and Drug Administration announced late last month that it would require classwide changes to labeling of benzodiazepines and certain opioids, including cough products containing opioids. The move is in response to the opioid epidemic.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research
More News: Children | Cough | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Psychiatry | Warnings